fda warning bpc-157 unapproved peptide peptides BPC-157: Prohibited and unapproved drug in supplements normal dose of bpc 157
Description
In tests, about 13 percent of people receiving the medication showed evidence of brain swelling, compared to less than 2 percent taking a placebo
These results appeared directly correlated with the increased levels of major lipolytic receptors, beta(3)-AR, found in the fat cells
These changes were not observed in placebo-treated patients
Shima Hadidchi, MD , offers this cutting-edge treatment to help patients achieve their weight loss goals
